SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-18-036043
Filing Date
2018-08-09
Accepted
2018-08-09 13:48:05
Documents
45
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q form10q.htm 10-Q 587697
2 EXHIBIT 31 ex31.htm EX-31 11432
3 EXHIBIT 32 ex32.htm EX-32 5048
  Complete submission text file 0001140361-18-036043.txt   4446393

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT bstc-20180630.xml EX-101.INS 992446
5 XBRL TAXONOMY EXTENSION SCHEMA bstc-20180630.xsd EX-101.SCH 31265
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bstc-20180630_cal.xml EX-101.CAL 38352
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bstc-20180630_def.xml EX-101.DEF 195552
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE bstc-20180630_lab.xml EX-101.LAB 475701
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bstc-20180630_pre.xml EX-101.PRE 307785
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Filer) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34236 | Film No.: 181004385
SIC: 2834 Pharmaceutical Preparations